Search Thermo Fisher Scientific
Infectious Disease Research—Resources
White paper: Genetic analysis tools for tuberculosis research
Thermo Fisher Scientific has been a leading provider of genetic analysis tools for understanding and monitoring respiratory pathogens. This knowledge helps improve human health and mitigate—and hopefully, ultimately prevent—global pandemics.
Webinar: Think Globally, Act Locally - The Importance of Coordinated Global and Community Genetic Surveillance Programs
Stephen S. Morse, PhD
Professor, Epidemiology; Director, Infectious Disease Epidemiology Certificate Program, Columbia University Medical Center
Webinar: Solutions for SARS-CoV-2 Strain Lineage Surveillance
Dr. Stephen Jackson
Associate Director, Product Applications, Genetic Sciences Division,
Thermo Fisher Scientific
Webinar: Strategies for epidemiological surveillance of emerging SARS-CoV-2 variants
Dr. Barbara Bartolini
National Institute for Infectious Diseases “L. Spallanzani”
(INMI), Italy
Dr. Luis Fernando de Macedo Brigido
Virology Center Instituto Adolfo Lutz
São Paulo, Brazil
Webinar: Host factors influencing pathogenesis of SARS-CoV-2
Dr. Fatah Kashanchi
Professor and Director
Laboratory of Molecular Virology
George Mason University
Jessica Gibson
CEO
Ariel Precision Medicine
White paper: Overview of the pathology, pathogenicity, and epidemiology of SARS-CoV-2
Research focused on the molecular pathogenesis and epidemiology of SARS-CoV-2, and the discovery of the virus itself, have been enabled by powerful genetic analysis tools such as quantitative PCR (qPCR), Sanger sequencing, next-generation sequencing (NGS), and fragment analysis using capillary electrophoresis and microarray technology. These solutions have been key in the identification of host and virus targets for drug and vaccine development research.
Please visit these other areas on our website for related information.